FDA Publishes Guidance to Help in Developing New ALS Therapies

After gathering input from patients, researchers, and advocates, the U.S Food and Drug Administration (FDA) has released new guidance on the development of therapies for amyotrophic lateral sclerosis (ALS). Among its recommendations, it is advising more communication with companies early on in the product development process, access to experimental therapies through compassionate use or the … Continue reading FDA Publishes Guidance to Help in Developing New ALS Therapies